Related Experiment Video
Updated: Dec 31, 2025

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
At last - linking ORMDL3 polymorphisms, decreased sphingolipid synthesis, and asthma susceptibility
Genetic variants in orosomucoid-like protein 3 (ORMDL3) are linked to childhood asthma. This study finds lower sphingolipids in children with asthma and specific ORMDL3 risk genotypes, suggesting a new therapeutic target.
Area of Science:
- Genetics
- Immunology
- Metabolism
Background:
- Asthma is a chronic respiratory disease with a genetic component.
- Polymorphisms in ORMDL3, a sphingolipid homeostasis regulator, are associated with childhood asthma.
- A direct link between ORMDL3 asthma-risk genotypes and altered sphingolipid synthesis was previously unestablished.
Purpose of the Study:
- To investigate the association between childhood asthma, sphingolipid levels, and ORMDL3 asthma-risk genotypes.
- To explore the role of sphingolipid dysregulation in the pathogenesis of childhood asthma.
Main Methods:
- Analysis of whole-blood sphingolipid levels in children with and without asthma.
- Genotyping for 17q21 asthma-risk variants, including ORMDL3.
- Correlation analysis between sphingolipid concentrations and specific genotypes.
Main Results:
- A significant association was found between nonallergic childhood asthma and lower whole-blood sphingolipid levels.
- Children with asthma-risk 17q21 genotypes exhibited lower sphingolipid concentrations.
- These findings establish a link between ORMDL3 genotypes and altered sphingolipid metabolism in childhood asthma.
Conclusions:
- Genetic variants in ORMDL3 may increase childhood asthma risk by disrupting sphingolipid synthesis.
- Sphingolipid metabolism represents a potential therapeutic target for childhood asthma.
- This study provides a mechanistic link between genetic predisposition and metabolic alterations in asthma.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Pleiotropy
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.